Showing results (1641-1650 of 1,762) with videos related to

Sort By:
Pageof 177
The Chinese Journal of Physiology|June 17, 2008
SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese womenGau-Tyan Lin, Hung-Fu Tseng, Chen-Kang Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 5, 2015
Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantationYao-Chung Liu, Sheng-Hsuan Chien, Nai-Wen Fan, et al.
American Journal of Hematology|August 25, 2010
High early mortality rate in elderly patients with multiple myeloma receiving a vincristine-doxorubicin-dexamethasone regimenHao-Wei Teng, Chung-Jen Teng, Wei-Shu Wang, et al.
Public Health Nursing (Boston, Mass.)|January 5, 2022
Community-based multiple screening for metabolic syndrome by innovative theory: A longitudinal studyAngela Shin-Yu Lien, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, et al.
Leukemia & Lymphoma|December 3, 2014
Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis BChia-Yun Wu, Liang-Tsai Hsiao, Tzeon-Jye Chiou, et al.
Omics : a Journal of Integrative Biology|February 7, 2009
Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in TaiwanGau-Tyan Lin, Hung-Fu Tseng, Cheng-Hong Yang, et al.
Blood Cancer Journal|October 16, 2012
How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?H-N Lin, C-Y Liu, J-T Pai, et al.
Hematological Oncology|July 29, 2016
Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detectionHao-Yuan Wang, Ching-Fen Yang, Tzeon-Jye Chiou, et al.
BMC Infectious Diseases|January 7, 2017
Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myelomaChun-Teng Huang, Chia-Jen Liu, Po-Shen Ko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Pageof 177